Kangstem Biotech’s core technology for knee osteoarthritis treatment, ‘바카라 사이트 디시,’ registered with U.S. patent

[by Ji, Yong Jun] Kangstem Biotech announced on July 8 that it has secured a U.S. patent for the core technology of ‘바카라 사이트 디시,’ an advanced bio-fusion complex and a potential fundamental treatment candidate for knee osteoarthritis.

This U.S. patent grants rights to a fusion composition combining stem cells with an acellular cartilage matrix for the treatment of joint diseases, including knee osteoarthritis, and represents a core technology that serves as the basis for the company’s entry into the U.S. market. Kangstem Biotech noted that the completion of clinical data and patent registrations in major international markets, such as the United States, Europe, and Japan, along with the technology transfer of 바카라 사이트 디시, is expected to provide a competitive advantage in future commercialization discussions.

바카라 사이트 디시 is an injectable treatment candidate for osteoarthritis that combines stem cells with a liquid acellular cartilage matrix. Developed as a fusion formulation, the technology is designed to maximize the regenerative efficacy of stem cells while improving patient convenience as an intra-articular ‘injection.’ According to the company, 바카라 사이트 디시 has demonstrated not only a favorable safety profile but also efficacy in pain relief, functional improvement, and structural restoration, including cartilage regeneration, with a single injection into the knee joint cavity.

“The registration of the U.S. patent reaffirms that 바카라 사이트 디시 is far more advanced than existing treatment technologies and holds strong competitiveness in the global market,” a Kangstem Biotech official said. “The patent covers not only 바카라 사이트 디시 itself but also related technologies, and we anticipate it will play a central role in future technology transfer negotiations and global commercialization efforts.”

On the other hand, 바카라 사이트 디시 is currently undergoing Phase 2a clinical trials at seven Korean medical institutions, with plans to complete administration to 108 patients by the end of the year. Through this study, Kangstem Biotech aims to demonstrate the statistical significance of 바카라 사이트 디시’s fundamental treatment effects, such as symptom relief and structural improvement, in the treatment of knee osteoarthritis.